Enhanced access to EGFR molecular testing in NSCLC using a cell-free DNA tube for liquid biopsy

被引:0
|
作者
May, T. E. [1 ]
Scudder, S. A. [2 ]
Joshi, S. J. [1 ]
Kohlmann, M. [3 ]
Shrestha, N. [3 ]
Lee, N. [3 ]
Hojbjerg, J. A. [4 ]
Lai, J. [5 ]
Madsen, A. T. [6 ]
Clement, M. S. [4 ]
Meldgaard, P. [7 ]
Tsourounis, M. [3 ]
Sorensen, B. [8 ]
Kohlmann, A. [9 ]
O'Donnell, P. [1 ]
Halait, H. [1 ]
机构
[1] Roche Mol Syst Inc USA, Dept Dev, Pleasanton, CA USA
[2] Roche Mol Syst Inc USA, Roche Sequencing Solut, Pleasanton, CA USA
[3] AstraZeneca PLC, Dev, Gaithersburg, MD USA
[4] Aarhus Univ, Clin Biochem, Aarhus, Denmark
[5] Roche Mol Syst Inc, Clin Operat, Pleasanton, CA USA
[6] Aarhus Univ, Oncol, Aarhus, Denmark
[7] Aarhus Univ, Clin Oncol, Aarhus, Denmark
[8] Aarhus Univ, Pathol, Aarhus, Denmark
[9] AstraZeneca PLC, Res, Gaithersburg, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1416P
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Pre-analytics Verification Studies for a Cell-Free DNA Collection Tube to Support Liquid Biopsy of NSCLC Patients Using Plasma-Based EGFR Molecular Testing
    Shabbeer, J.
    May, T.
    Joshi, S.
    Kohlmann, M.
    Shrestha, N.
    Lee, N.
    Lai, J.
    Scudder, S.
    Tsourounis, M.
    Kohlmann, A.
    O'Donnell, P.
    Halait, H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1237 - 1238
  • [2] Liquid Biopsy: EGFR Mutation Testing Using Cell-free DNA and the GeneReader Workflow in a Cohort of Patients with Advanced EGFR-mutant NSCLC
    Seitz, J.
    Moskalev, E.
    Fuchs, F.
    Haller, F.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (02): : S51 - S51
  • [3] Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients
    Marta Sesé
    Rosa Somoza
    Inmaculada Maestu
    Maria Martín Ureste
    Alfredo Sanchez
    Juan Felipe Cordoba
    Irene Sansano
    Griselda Venturas
    Santiago Ramón y Cajal
    Javier Hernández-Losa
    Oncology and Therapy, 2019, 7 : 131 - 139
  • [4] Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients
    Sese, Marta
    Somoza, Rosa
    Maestu, Inmaculada
    Martin Ureste, Maria
    Sanchez, Alfredo
    Felipe Cordoba, Juan
    Sansano, Irene
    Venturas, Griselda
    Ramon y Cajal, Santiago
    Hernandez-Losa, Javier
    ONCOLOGY AND THERAPY, 2019, 7 (02) : 131 - 139
  • [5] Liquid biopsy using extracellular vesicular DNA for EGFR mutation testing in the patients with NSCLC
    Hur, Jae Young
    Kim, Hee Jung
    Choi, Chang-Min
    Lee, Jae Cheol
    Lee, Kye Young
    CANCER RESEARCH, 2017, 77
  • [6] Cell-Free DNA Fragmentomics in Liquid Biopsy
    Ding, Spencer C.
    Lo, Y. M. Dennis
    DIAGNOSTICS, 2022, 12 (04)
  • [7] Liquid Biopsy for Glioma Using Cell-Free DNA in Cerebrospinal Fluid
    Otsuji, Ryosuke
    Fujioka, Yutaka
    Hata, Nobuhiro
    Kuga, Daisuke
    Hatae, Ryusuke
    Sangatsuda, Yuhei
    Nakamizo, Akira
    Mizoguchi, Masahiro
    Yoshimoto, Koji
    CANCERS, 2024, 16 (05)
  • [8] PROGRESS TOWARD LIQUID BIOPSY USING CELL-FREE DNA IN HEPATOBLASTOMA
    Hiyama, Eiso
    Kojima, Masato
    Toge, Ryo
    Kurihara, Sho
    Saeki, Isamu
    Nagae, Genta
    Honda, Shohei
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S47 - S48
  • [9] Liquid Biopsy for EGFR Genotyping Using Cell-Free DNA and Extracellular Vesicular DNA of Pleural Effusion in Pulmonary Adenocarcinoma Patients
    Lee, J. S.
    Hur, J. Y.
    Kim, I. A.
    Kim, H. J.
    Choi, C.
    Lee, J. C.
    Kim, W. S.
    Lee, K. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2213 - S2213
  • [10] Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
    Luo, Huiyan
    Wei, Wei
    Ye, Ziyi
    Zheng, Jiabo
    Xu, Rui-hua
    TRENDS IN MOLECULAR MEDICINE, 2021, 27 (05) : 482 - 500